Maraviroc 150mg Tablets

Maraviroc 150mg is an antiretroviral medicine used with other HIV medicines for HIV-1 infection that is confirmed to be CCR5-tropic. It is not used alone and should not be started until tropism testing shows that the virus uses the CCR5 coreceptor rather than CXCR4 or mixed/dual tropism. Maraviroc blocks CCR5 on immune cells, reducing entry of susceptible HIV strains into target cells. Patients should continue safer-sex and transmission-prevention measures because viral suppression depends on the complete regimen and adherence.
Take Maraviroc 150mg exactly as part of the prescribed HIV regimen. Do not miss doses or stop without HIV-clinic advice. Confirm interaction-based dosing whenever other medicines change.
Maraviroc blocks the CCR5 coreceptor on host cells, preventing CCR5-tropic HIV-1 from entering those cells.
Possible effects include cough, fever, dizziness, rash, abdominal pain, tiredness, and upper respiratory symptoms. Serious concerns include liver injury, severe allergic reaction, low blood pressure on standing, severe skin reaction, and infections during immune recovery.
Review CCR5 tropism result, full ART regimen, liver disease, kidney disease, low blood pressure, heart disease, hepatitis B/C, pregnancy, breastfeeding, strong CYP3A inhibitors or inducers, and adherence barriers.
CCR5-tropic HIV-1 infection as part of combination antiretroviral therapy when maraviroc is prescribed.
Adds a host-entry blocking mechanism to HIV treatment for patients whose virus is CCR5-tropic and whose regimen is interaction-adjusted.
Maraviroc 150mg is used with other HIV medicines for CCR5-tropic HIV-1 infection.
Maraviroc works only when HIV uses the CCR5 coreceptor; it is not recommended for CXCR4 or mixed/dual tropic virus.
No. It must be used as part of a complete antiretroviral regimen.
CYP3A inhibitors or inducers can greatly change maraviroc exposure, so dosing depends on the companion medicines.
Rash with fever, jaundice, severe dizziness, fainting, or signs of liver trouble need urgent review.
Maraviroc, CCR5 antagonist, CCR5 tropic HIV treatment, Antiretroviral combination therapy, Tropism testing, CYP3A dose adjustment, AR: Maraviroc أقراص, FR: Maraviroc comprimé, PT: Maraviroc comprimido, ES: Maraviroc tableta, RU: Maraviroc таблетки, ID: Maraviroc, VI: Maraviroc viên nén, MS: Maraviroc, TL: Maraviroc tableta, ZH-SG: Maraviroc 片剂
International B2B Enquiry
Send a structured B2B enquiry for Maraviroc 150mg Tablets under Antiviral. Global Medicines Export helps international buyers review product information, pack details, quantity requirements, destination-market needs, quotation support and export documentation coordination from India.
Product name, required strength or pack, expected quantity, destination country, buyer type and preferred manufacturer if any.
Availability, quotation support, documentation expectations and shipment-ready order communication can be reviewed before confirmation.
Commercial invoice, packing information, manufacturer details, batch details and supporting documents where applicable and available.
Product availability, quotation, and documentation support are coordinated for international B2B enquiries.
Maraviroc 150mg Tablets